Cameron Dell

735 total citations
6 papers, 300 citations indexed

About

Cameron Dell is a scholar working on Hematology, Molecular Biology and Neurology. According to data from OpenAlex, Cameron Dell has authored 6 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Cameron Dell's work include Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Peptidase Inhibition and Analysis (2 papers). Cameron Dell is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Peptidase Inhibition and Analysis (2 papers). Cameron Dell collaborates with scholars based in United States. Cameron Dell's co-authors include Ashraf Badros, Olga Goloubeva, Ning Ma, Aaron P. Rapoport, Sunita Philip, Zeba N. Singh, Mehmet H. Kocoglu, Elizabeth Hyjek, Alexander M. Lesokhin and Ahmet Doǧan and has published in prestigious journals such as Blood, Neurology and Neurocritical Care.

In The Last Decade

Cameron Dell

6 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cameron Dell United States	5	157	145	96	80	72	6	300
Carmen Martínez‐Chamorro Spain	9	341 2.2×	173 1.2×	128 1.3×	38 0.5×	21 0.3×	15	383
Lida Bubuteishvili‐Pacaud United States	8	71 0.5×	316 2.2×	84 0.9×	32 0.4×	147 2.0×	21	357
Maxim Yankelevich United States	7	25 0.2×	103 0.7×	49 0.5×	43 0.5×	50 0.7×	20	192
Melita Kenealy Australia	10	132 0.8×	69 0.5×	73 0.8×	35 0.4×	10 0.1×	20	269
MR Motta Italy	7	306 1.9×	101 0.7×	116 1.2×	76 0.9×	13 0.2×	9	356
Federica Cocito Italy	10	159 1.0×	83 0.6×	118 1.2×	27 0.3×	9 0.1×	22	231
Anke Krause Germany	8	89 0.6×	105 0.7×	130 1.4×	55 0.7×	22 0.3×	10	308
Sung-Nam Lim South Korea	9	100 0.6×	80 0.6×	43 0.4×	17 0.2×	15 0.2×	36	262
Maaike de Bie Netherlands	9	127 0.8×	86 0.6×	56 0.6×	36 0.5×	42 0.6×	17	321
Maria Carmen Martorelli Italy	8	153 1.0×	82 0.6×	64 0.7×	15 0.2×	6 0.1×	17	219

Countries citing papers authored by Cameron Dell

Since Specialization

Citations

This map shows the geographic impact of Cameron Dell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Dell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Dell more than expected).

Fields of papers citing papers by Cameron Dell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Dell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Dell. The network helps show where Cameron Dell may publish in the future.

Co-authorship network of co-authors of Cameron Dell

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Dell. A scholar is included among the top collaborators of Cameron Dell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Dell. Cameron Dell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Badros, Ashraf, Elizabeth Hyjek, Ning Ma, et al.. (2017). Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma. Blood. 130(10). 1189–1197. 146 indexed citations

2.

Dell, Cameron, Olga Goloubeva, Aaron P. Rapoport, et al.. (2017). Similar Survival for African American and Caucasian Multiple Myeloma Patients Receiving Auto-SCT. Blood. 130. 2177–2177. 1 indexed citations

3.

Hwang, David Y., Cameron Dell, Mary J. Sparks, et al.. (2017). Factors Considered by Clinicians when Prognosticating Intracerebral Hemorrhage Outcomes. Neurocritical Care. 27(3). 316–325. 15 indexed citations

4.

Badros, Ashraf, Elizabeth Hyjek, Ning Ma, et al.. (2016). Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 128(22). 490–490. 17 indexed citations

5.

Hwang, David Y., Cameron Dell, Mary J. Sparks, et al.. (2015). Clinician judgment vs formal scales for predicting intracerebral hemorrhage outcomes. Neurology. 86(2). 126–133. 77 indexed citations

6.

Badros, Ashraf, Mehmet H. Kocoglu, Ning Ma, et al.. (2015). A Phase II Study of Anti PD-1 Antibody Pembrolizumab, Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 126(23). 506–506. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact